Recruiting
EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.
Phase 1 / Phase 2 · 1 site
Search the registry
Find clinical trials
Searching 2,585 mirrored studies from ClinicalTrials.gov.
Create a profile
to see personalised match scores.
2,585 studies found
Recruiting
Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Phase 3 · 1 site
Recruiting
Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
Phase 3 · 9 sites
Potential match only. Final eligibility is determined by the study team.